A recent study found permanent pacemaker infection (PPMI) in 2.09% patients, with infections more prevalent in devices ...
FDA agreed that data from the Phase 2a diSArm study support advancement of AP-SA02 to a Phase 3study First bacteriophage company to advance a clinical candidate to ...
Bacteria learned to survive by developing their own defence mechanism against antibiotic use, finds a 2025 study report by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results